Aratana Gets Rights To Two Compounds For Animal Use
March 4, 2011
Aratana Therapeutics Inc. of Kansas City, Kan., reported today that it has entered into a license agreement with RaQualia Pharma Inc. to develop two compounds from RaQualia’s human clinical development portfolio for companion animal use. As part of the agreement, Aratana will be granted global rights for development and commercialization of the licensed animal health… Continue reading...